You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Use of NSAIDs in treating patients with arthritis
|
|---|---|
| Published in |
Arthritis Research & Therapy, July 2013
|
| DOI | 10.1186/ar4174 |
| Pubmed ID | |
| Authors |
Leslie J Crofford |
| Abstract |
Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost universally describe pain and stiffness as important contributors to reduced health-related quality of life. Of the treatment options available, NSAIDs are the most widely used agents for symptomatic treatment. NSAIDs are effective anti-inflammatory and analgesic drugs by virtue of their ability to inhibit biosynthesis of prostaglandins at the level of the cyclooxygenase enzyme. However, many of the adverse effects of NSAIDs are also related to inhibition of prostaglandin production, making their use problematic in some patient populations. For the clinician, understanding the biology of prostaglandin as it relates to gastrointestinal, renal, and cardiovascular physiology and the pharmacologic properties of specific NSAIDs is key to using these drugs safely. Of particular importance is the recognition of co-morbid conditions and concomitant drugs that may increase the risk of NSAIDs in particular patients. In patients with risk factors for NSAID toxicity, using the lowest dose of a drug with a short half-life only when it is needed is likely to be the safest treatment option. For those patients whose symptoms cannot be managed with intermittent treatment, using protective strategies is essential. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 30% |
| Canada | 2 | 20% |
| United States | 1 | 10% |
| Australia | 1 | 10% |
| Unknown | 3 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 30% |
| Scientists | 3 | 30% |
| Science communicators (journalists, bloggers, editors) | 2 | 20% |
| Practitioners (doctors, other healthcare professionals) | 2 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 731 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | <1% |
| Malaysia | 1 | <1% |
| Australia | 1 | <1% |
| India | 1 | <1% |
| Argentina | 1 | <1% |
| Spain | 1 | <1% |
| Greece | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 723 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 122 | 17% |
| Student > Master | 100 | 14% |
| Student > Ph. D. Student | 79 | 11% |
| Student > Postgraduate | 50 | 7% |
| Researcher | 47 | 6% |
| Other | 100 | 14% |
| Unknown | 233 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 123 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 116 | 16% |
| Biochemistry, Genetics and Molecular Biology | 61 | 8% |
| Agricultural and Biological Sciences | 57 | 8% |
| Chemistry | 25 | 3% |
| Other | 91 | 12% |
| Unknown | 258 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2023.
All research outputs
#1,948,573
of 25,728,855 outputs
Outputs from Arthritis Research & Therapy
#302
of 3,411 outputs
Outputs of similar age
#16,185
of 210,408 outputs
Outputs of similar age from Arthritis Research & Therapy
#4
of 34 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,411 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,408 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.